Platelet Function Testing - Round Table Discussion

Roundtable Discussion

 
SESSION 3: Platelet Reactivity Testing - Treatment Options for High-risk PCI Patients

CHAIR

Robert Storey
Professor and Honorary Consultant in Cardiology, Department of Cardiovascular Science
University of Sheffield, UK

PANEL

Jean-Philippe Collet, Groupe Hospitalier Pitié-Salpêtrière, Paris, FR
Antonio Colombo, San Raffaele Hospital, Milan, IT
Jeff Daheln, Chief Scientific Officer, Accumetrics, US

In the third session from the Platelet Reactivity Testing Round Table, the panel discuss treatment options for high-risk PCI patients.
Among the many fascinating points discussed in this session are a number of key issues including:

Time Discussion Point
01'10 Evidence regarding antiplatelet drug response
03'45 Treatment options for antiplatelet therapy in the cathlab
08'10 Interpreting the finding of ARCTIC study
15'14 Bleeding risk in patients with complex disease
17'40 Is there a role for platelet function testing in assessing compliance?
18'30 Value of platelet function testing for assessing whether there is a drug response
22'30 Is the P2'i'12 assay robust enough to titrate a response?
Robert Storey, Professor and Honorary Consultant in Cardiology, Department of Cardiovascular Science, University of Sheffield, UK (Chair)
Jean-Philippe Collet, Groupe Hospitalier Pitié-Salpêtrière, Paris, France
Antonio Colombo, San Raffaele Hospital, Milan, Italy
Jeff Daheln, Chief Scientific Officer, Accumetrics, US
Designed to support the continuous education of practicing physicians, this roundtable shares leading opinion and addresses the following questions and key educational objectives:
  • Increase physician awareness of the multidisciplinary role of antiplatelet therapy
  • Increase understanding of the role of platelet function testing in high-risk PCI
  • Explain the emerging role of PFT in PAD
  • Assess the role of antiplatelets in neuro-endovascular procedures

This round table discussion is intended for an international audience, specifically interventional cardiologists, interventional radiologists and aligned healthcare professional involved with antiplatelet therapy.

The Round Table Event was supported by Accumetrics.